arrow
K

Kathryn F. Mileham

Wake Forest University
H指数:20
被引数:2,817

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Full Dose SBRT in Combination With Mediastinal Chemoradiation for Locally Advanced, Non-Small Cell Lung Cancer: A Practical Guide for Planning, Dosimetric Results From a Phase 2 Study, and a Treatment Planning Guide for the Phase 3 NRG Oncology LU-008 Trial
2023-11-019
PRE
Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study
2023-10-010
PRE
Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2023-04-140
PRE
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib

一项随机,开放标签的II期研究,评估了Emibetuzumab联合厄洛替尼和Emibetuzumab单药治疗对厄洛替尼获得性耐药的MET免疫组织化学阳性NSCLC患者

2022-06-0119
OAAI
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
2021-01-1063
PREAI
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer ABOUND.sqm): A Phase III Randomized Clinical Trial

纳米颗粒白蛋白结合紫杉醇加卡铂诱导后纳米颗粒白蛋白结合紫杉醇维持治疗鳞状非小细胞肺癌比比皆是。sqm): 一项III期随机临床试验

2021-01-019
OAAI